SCHEDULE: Dimensional Fund Advisors LP Reports 5.9% Stake in Prestige Consumer Healthcare Inc

Dimensional Fund Advisors LP reports beneficial ownership of 5.9% of Prestige Consumer Healthcare Inc's common stock as of December 31, 2024.

Summary

• Dimensional Fund Advisors LP filed a Schedule 13G indicating beneficial ownership of 2,907,066 shares of Prestige Consumer Healthcare Inc's common stock.
• This represents approximately 5.9% of the company's outstanding shares.
• The filing date is January 23, 2025, and the event date requiring the filing was December 31, 2024.
• Dimensional Fund Advisors LP, as an investment advisor, manages various funds that own these securities but disclaims beneficial ownership.
• Dimensional has sole voting power over 2,827,065 shares and sole dispositive power over 2,907,066 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The filing indicates a significant investment by Dimensional Fund Advisors LP in Prestige Consumer Healthcare Inc.

Industry Context

Schedule 13G filings are standard practice for investment advisors holding significant positions in publicly traded companies, providing transparency to the market.

Comparison to Industry Standards

• Similar filings are common among large investment advisors like BlackRock, Vanguard, and State Street when their holdings in a company exceed 5%.
• These filings are a routine part of regulatory compliance and portfolio management.

Stakeholder Impact

• The filing informs shareholders of Prestige Consumer Healthcare Inc about a significant ownership stake held by Dimensional Fund Advisors LP.

Key Dates

Keywords

Prestige Consumer Healthcare Inc, Dimensional Fund Advisors LP, Schedule 13G, Beneficial Ownership, Investment Advisor, Common Stock